Let's break down Granules India Limited (GRANULES) — from its financial performance to how the market is valuing the stock.
Granules Revenue Trend
The top line held its ground: Granules India Limited came in at ₹4,495 Cr in FY2025, on par with FY2024.
On a 10-year view, revenue grew at 13.3% annually from ₹1,293 Cr to ₹4,495 Cr. Healthy growth, and clearly ahead of the broader market.
Granules India Limited is a mid-sized pharmaceuticals company by revenue, with a top line of ₹4,495 Cr.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹4,495 Cr | -0.4% |
| FY2024 | ₹4,511 Cr | -0.3% |
| FY2023 | ₹4,526 Cr | +19.6% |
| FY2022 | ₹3,783 Cr | +16.8% |
| FY2021 | ₹3,238 Cr | — |
View Granules India Limited's full 10-year revenue trend with CAGR analysis →
Granules Profitability
At ₹502 Cr, Granules India Limited's FY2025 net profit was 23.7% ahead of FY2024.
Margins moved in the right direction, with net margin rising to 11.2% from 9.0%.
Looking at per-share numbers, diluted EPS was ₹20.68 in FY2025 — up from ₹16.72.
Is Granules Undervalued
Based on the P/E Ratio model, Granules India Limited's fair value works out to ₹429 — 45.9% downside from where it trades today.
Granules India Limited shares are currently trading at ₹793.80.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹429 | 45.9% downside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Granules India Limited with detailed assumptions →
Granules Shareholding Pattern
Promoter stake dipped to 38.0% from 38.8% over 4 quarters — something to monitor.
On the foreign institutional side, the holding is 15.3% as of March 2026 — up from 15.2%.
DII holding is at 17.0%, down from 22.4% in the year-ago quarter.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 38.0% | 15.3% | 17.0% | 29.7% |
| Dec 2025 | 38.8% | 13.6% | 17.5% | 30.1% |
| Sep 2025 | 38.8% | 14.1% | 17.9% | 29.2% |
| Mar 2025 | 38.8% | 15.2% | 22.4% | 23.6% |
Track quarterly shareholding changes for Granules India Limited →
Granules Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
Total assets stood at ₹62.53B at the end of FY2025, up 13.3% from ₹55.21B a year earlier.
Property, Plant & Equipment is the largest block at 39.3%, followed by Inventories at 21.5% and Receivables at 15.1%.
Equity makes up 59.4% of liabilities and equity, with debt at 23.3% and operating liabilities at 17.3%. Over the year, debt is up 10.6% and equity is up 15.2%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 4.66B |
| Receivables | 9.42B |
| Inventories | 13.43B |
| Property, Plant & Equipment | 24.59B |
| Investments | 220.39M |
| Intangibles & Goodwill | 2.12B |
| Other Assets | 8.08B |
| Category | Value |
|---|---|
| Equity | 37.16B |
| Short-term Debt | 9.84B |
| Long-term Debt | 4.71B |
| Trade Payables | 7.26B |
| Other Liabilities | 3.56B |
Granules Key Highlights
Pulling it all together, here's what the numbers say about Granules India Limited (GRANULES) heading into the next fiscal year.
Revenue of ₹4,495 Cr in FY2025, broadly flat versus the prior year.
Long-term revenue has been compounding at 13.3% annually over 10 years.
The company is profitable, with a net margin of 11.2% and net income of ₹502 Cr.
The P/E Ratio model implies 45.9% downside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Granules India Limited's detailed profile on Craytheon.